QCG
RXST icon

Quadrant Capital Group’s RxSight RXST Stock Holding History

Quadrant Capital Group’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,778
Closed -$11K – 2307
2026
Q1 		$11K Sell
1,778
-246
-12% -$2.04K ﹤0.01% 2170
2025
Q4 		$21.1K Sell
2,024
-5,255
-72% -$52.7K ﹤0.01% 1971
2025
Q3 		$65.4K Buy
+7,279
New +$63.9K ﹤0.01% 1580
2025
Q2 		– Sell
-227
Closed -$5.73K – 2355
2025
Q1 		$5.73K Buy
+227
New +$6.75K ﹤0.01% 2327

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Quadrant Capital Group's RXST Position: Q2 2026 in Review

Quadrant Capital Group sold out of RxSight (RXST) in Q2 2026, closing a stake of 1,778 shares — an estimated $11K sold.

Quadrant Capital Group first reported a position in RXST in Q1 2025 and held it in 4 quarters. The position peaked at $65.4K in Q3 2025. 152 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Quadrant Capital Group reported no remaining RxSight position as of Q2 2026 after selling out during the quarter.
  • Quadrant Capital Group sold 1,778 RxSight shares in Q2 2026, an estimated $11K.
  • Quadrant Capital Group first reported a position in RxSight in Q1 2025 and held it in 4 quarters.
  • Quadrant Capital Group's RxSight position peaked at $65.4K in Q3 2025.
  • 152 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.